We studied association of Oprm1 gene polymorphisms with signs of N-(1-phenethyl-4-piperidyl)propionanilide intoxication in rats. It was found that the rate of intoxication in laboratory animals depends on genetic features. A polymorphic variant rs105312806 of Oprm1 gene can be a possible marker of animal sensitivity to opioid receptor agonists. This hypothesis was supported by differences in the rats of intoxication signs such as time to lateral posture and sleep duration in homozygous rats carrying different alleles. In rats with AA genotype, the time to lateral posture was shorter by 1.3 times and sleep duration was longer by 3.5 times than in carriers of GG genotype.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Glantz SA. Primer of Biostatistics. Moscow, 1999. Russian.
Zotova IV, Nikitin AG, Fattakhova EN, Brovkin AN, Khodyrev DS, Lavrikova EY, Isaeva MY, Kosukhina AS, Nosikov VV, Zateyshchikov DA. The affect of influence of genes” polymorphisms CYP2C9 and VKORC1 on the safety of the therapy by warfarin. Klin. Praktika. 2013;(4):3-10. Russian.
Ivanet NN, Anokhina IP, Vinnikova MA. Narcology: a National Guidance. Moscow, 2008. Russian.
Kovalenko VN, Kuchmenko EB, Mkhitaryan LS. The role of single nucleotide polymorphisms and microRNAs in the pathogenesis of cardiovascular diseases (review). Zh. Nats. Akad. Med. Nauk Ukrainy. 2014;20(1):62-73. Russian.
Kukes VG. Clinical Pharmacokinetics: Theoretical, Applied, and Analytical Aspects: Guidance. Moscow, 2009. Russian.
Sychev DA, Ignatyev IV, Gassanov NA, Kukes VG. Clinical pharmacogenetics of the biotransformation systems and carriers of medications: the fashion or the applied direction? Tikhookean. Med. Zh. 2006;(4):21-26. Russian.
Ginosar Y, Davidson E.M, Meroz Y, Blotnick S, Shacham M, Caraco Y. Mu-opioid receptor (A118G) single-nucleotide polymorphism affects alfentanil requirements for extracorporeal shock wave lithotripsy: a pharmacokinetic-pharmacodynamic study. Br. J. Anaesth. 2009;103(3):420-427.
Kasai S, Ikeda K. Pharmacogenomics of the human μ-opioid receptor. Pharmacogenomics. 2011;12(9):1305-1320.
Matthes HW, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I, Befort K, Dierich A, Le Meur M, Dollé P, Tzavara E, Hanoune J, Roques BP, Kieffer BL. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature. 1996;383:819-823.
Sia AT, Lim Y, Lim EC, Goh RW, Law HY, Landau R, Teo YY, Tan EC. A118G single nucleotide polymorphism of human mu-opioid receptor gene influences pain perception and patient-controlled intravenous morphine consumption after intrathecal morphine for postcesarean analgesia. Anesthesiology. 2008;109(3):520-526.
The Opiate Receptors. Pasternak GW, ed. New York, 2011.
Uhl GR, Sora I, Wang Z. The mu opiate receptor as a candidate gene for pain: polymorphisms, variations in expression, nociception, and opiate responses. Proc. Natl Acad. Sci. USA. 1999;96(14):7752-7755.
Walter C, Lötsch J. Meta-analysis of the relevance of the OPRM1 118A>G genetic variant for pain treatment. Pain. 2009;146(3):270-275.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 165, No. 1, pp. 84-87, January, 2018
Rights and permissions
About this article
Cite this article
Varlamova, O.V., Babkin, A.V., Berdinskikh, I.S. et al. Polymorphism of Oprm1 Gene and Its Association with Manifestations of N-(1-Phenethyl-4-Piperidyl)Propionanilide Intoxication in Rats. Bull Exp Biol Med 165, 72–74 (2018). https://doi.org/10.1007/s10517-018-4102-1
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-018-4102-1